
Prime Minister Boris Johnson’s sudden change of position that the UK is now expecting a no-deal scenario with the European …

UK Government ministers ignored warnings three weeks ago that the country should go into a temporary full lockdown to reduce …

Newly released data has revealed that COVID-19 has resulted in many more deaths than influenza or pneumonia in England and …

The National Institute for Health and Care Excellence (NICE) has recommended Sandoz’s Rizmoic (naldemedine) for the treatment of opioid-induced constipation …

The UK Government’s track and trace app for COVID-19 has finally launched in England and Wales, after months of delays …

It has been revealed that Bavencio (avelumab), jointly developed by Merck KGaA and Pfizer, has been approved by the UK …

The UK Government has signed a new deal with Johnson & Johnson and Novavax to secure 90 million orders of …

The British government has contacted medicine suppliers urging them to stockpile drugs for a possible no-deal Brexit, despite the pressure …

The UK Government’s Department for Business, Energy & Industrial Strategy has revealed a new pledge of an additional £100 million …

NICE has revealed its recommendation of Astellas’ gilteritinib for routine use as a monotherapy on the NHS in England and …

NICE has announced it has recommended Takeda’s Adcetris (brentuximab vedotin), in combination with cyclophosphamide, doxorubicin and prednisone (CHP), for use …

A coalition of UK universities have come together to build a new clinical trial and drug testing platform to evaluate …

The UK Government warned when relaxing lockdown measures on 23 June that it would not hesitate to lock down any …

British Prime Minister Boris Johnson announced an extensive rollback of existing lockdown measures to restrict the spread of COVID-19 in …

Roche’s Rozlytrek (entrectinib) has secured recommendation for NHS use in England and Wales after NICE backed the drug in final …